CRISPR gene drives bias inheritance in pests, advancing population-level control while raising questions about resistance and ...
How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.
A new CRISPR-based tool that is directly used on patients' cancer cells can identify genes and regulatory elements driving ...
One year after receiving CRISPR gene editing therapy at CHOP, a Delaware County baby is thriving, and doctors want to expand ...
Can Ben Lamm save the planet? He thinks so. Short, stocky and unassuming with a puckish sense of humor, the shaggy-haired ...
CNBC's Becky Quick reports on the progress of KJ Muldoon, the first patient to receive a personalized CRISPR-based gene ...
Investor's Business Daily on MSN
CRISPR Therapeutics stock sees RS rating rise to 73
CRISPR Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating ...
Similar to the trends during the last few weeks, Cathie Wood’s ARK exchange-traded funds continued to step up bets on AI and ...
Cathie Wood's ARK Invest bought Recursion Pharmaceuticals and CRISPR Therapeutics while selling PagerDuty, Teradyne, and ...
Cellares, the first Integrated Development and Manufacturing Organization (IDMO), and the University of Wisconsin (UW) School ...
13d
Gene Editing Has Struggled To Go Commercial. This Nobel Laureate Has A $1 Billion Plan To Fix That.
Crispr’s ability to cut genetic code like scissors has just started to turn into medicines. Now, gene editing pioneer ...
Comparative analysis of cells with high or low CD47 surface expression using DrugZ revealed CD47 itself as the top hit, validating the screens. Notably, DNAJC13 emerged as a consistent and robust ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results